Skip to main content
. 2017 Jun 8;7:3057. doi: 10.1038/s41598-017-03130-z

Figure 4.

Figure 4

TNF-α markedly upregulates CX3CL1 production by HUVECs. (A) HUVECs were stimulated with TNF-α (5 ng/ml) up to 8 hours and CX3CL1 mRNA expression was analyzed by real-time RT-PCR at the indicated time-points. (B) HUVECs were treated with various concentrations of TNF-α (1 to 10 ng/ml) for 4 hours, and the expression of CX3CL1 was analyzed by real-time RT-PCR. (C) HUVECs were stimulated with various concentrations of TNF-α (1 to 10 ng/ml) for 18 hours and the amount of CX3CL1 in the culture supernatant was quantified by conventional ELISA. (D) Purified monocytes were treated with or without IS for 48 hr, and the supernatant (MCM: monocyte-conditioned media) of each culture was harvested. Control or IS-treated monocyte-conditioned media (Con- or IS-MCM) was added to confluent, cultured HUVECs in the presence of anti-TNF-α Ab or control IgG, followed by a 4 hr incubation. CX3CL1 mRNA expression in treated HUVECs was analyzed by real-time RT-PCR. Expression of β-actin was used as a normalization control. Bar graphs show the mean ± SEM of three to four independent experiments. *p < 0.05 and **p < 0.01: compared to no TNF-α treatment group by two-tailed paired t-test (B and C).